2m 2m 2m 2m 2m 2m 2m
ROYAL PHARM -A (RPRX)
NASDAQ
$61.30-$0.01 (-0.02%)
Price as of Aug 21, 2026 7:30 PM EDT- $27.2BMarket Cap
- 72.08%1-Year Change
- BiotechnologyIndustry
ROYAL PHARM -A (RPRX)
$61.30-$0.01 (-0.02%)
RPRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $61.31 | ||
Change | +$0.73 (+1.21%) | ||
Open | $60.53 | ||
High | $61.60 | ||
Low | $60.37 | ||
Previous Close | $60.58 | ||
Volume | 2,325,104 | ||
30-Day Average Volume | 2,763,940 | ||
1-Week Change | 4.62% | ||
1-Month Change | 5.37% | ||
1-Year Change | 72.08% | ||
3-Year Change | 123.31% | ||
5-Year Change | 76.69% | ||
Fundamentals | |||
Shares Outstanding | 443.2M | ||
Total Assets | $19.8B | ||
Market Cap | $27.2B | ||
Enterprise Value | $35.3B | ||
Period: QTR TTM FY | |||
Revenue | $638.0M | ||
Net Income | $17.9M | ||
Free Cash Flow | $728.5M | ||
EBIT | $17.9M | ||
EBITDA | $19.2M | ||
Net Working Capital | $1.1B | ||
EPS | $0.04 | ||
Enterprise Value/EBITDA | 1,842 | ||
Enterprise Value/Revenue | 55 | ||
P/B | 3 | ||
P/E | 1,533 | ||
PEG | -16 | ||
Price/Free Cash Flow | 37 | ||
Price/Operating Cash Flow | 37 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 1.53% | ||
Trailing Annual Dividend Yield | 1.51% | ||
Ex-Dividend Date | 08/14/2026 | ||
Last Split Factor | 1 : 4 | ||
Last Split Date | 10/15/2010 | ||
Earnings & Revenue
Annual Dividend Yield